Real-world use of carfilzomib therapy among patients with existing cardiovascular medical history
Real-world use of carfilzomib therapy among patients with existing cardiovascular medical history
Maintenance with weekly carfilzomib in elderly newly diagnosed multiple myeloma
Twice-weekly vs once-weekly Krd in early relapsed refractory multiple myeloma
HORIZON: Melflufen in high risk relapsed refractory multiple myeloma patients with extramedullary disease
Improved outcomes from quadruplet KCRD induction in newly diagnosed myeloma patients
What is the role of autologous stem cell transplant in multiple myeloma?
First results of the GMMG-CONCEPT trial for multiple myeloma
Iberdomide in combination with dexamethasone for multiple myeloma
PLEIADES: Daratumumab combinations for multiple myeloma
Treatment options for high risk relapsed/refractory multiple myeloma
Ruxolitinib, lenalidomide and methylprednisolone for relapsed/refractory multiple myeloma
BCMA: A new biomarker for multiple myeloma